IP Library Granted Patent US 8,961,953
Granted Patent B2
US 8,961,953 · App. 12/922,377 · Granted Feb 24, 2015

Synbiotic mixture

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,961,953
App. No.
12/922,377
Granted
Feb 24, 2015
Kind
B2
Abstract

This invention relates to a preparation comprising N-acetyl-lactosamine and/or an oligosaccharide containing N-acetyl-lactosamine and a probiotic Lactobacillus sp. The invention extends to nutritional compositions comprising said preparation and to the use of the preparation in the prevention and treatment of pathogenic infections of the gastro-intestinal and upper respiratory tracts.

Claims (7)

1. A composition selected from the group consisting of an infant formula and a growing up milk for treatment of pathogenic infections of a gastro-intestinal tract or an upper respiratory tract, the composition comprising:

lacto-N-neotetraose in an amount of 0.1 to 3% by dry weight of the composition; and

a probiotic Lactobacillus sp selected from the group consisting of (i) Lactobacillus rhamnosus CGMCC 1.3724 in an amount between 10 2 and 10 10 cfu for each gram of the lacto-N-neotetraose and (ii) Lactobacillus reuteri DSM 17938 in an amount between 10 2 and 10 10 cfu for each gram of the lacto-N-neotetraose.

2. The composition of claim 1 wherein the probiotic Lactobacillus sp is Lactobacillus rhamnosus CGMCC 1.3724.

3. The composition of claim 1 wherein the probiotic Lactobacillus sp is Lactobacillus reuteri DSM 17938.

4. The composition of claim 1 wherein the lacto-N-neotetraose is the only oligosaccharide containing N-acetyl-lactosamine in the composition.

5. A food product comprising 0.3 to 4% by weight based on dry matter of a component for treatment of pathogenic infections of a gastro-intestinal tract or an upper respiratory tract, the component comprising lacto-N-neotetraose in an amount of 0.1 to 3% by dry weight of the food product and further comprising a probiotic Lactobacillus sp selected from the group consisting of Lactobacillus rhamnosus CGMCC 1.3724 and Lactobacillus reuteri DSM 17938.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →